Related references
Note: Only part of the references are listed.miR-126 regulates the proliferation, migration, invasion, and apoptosis of non-small lung cancer cells via AKT2/HK2 axis
Bin Huang et al.
IUBMB LIFE (2023)
The role of miRNA-377 as a tumor suppressor in lung cancer by negative regulation of genes belonging to ErbB signaling pathway
Saba Hashemi et al.
MOLECULAR BIOLOGY REPORTS (2022)
miR-129-2 upregulation induces apoptosis and promotes NSCLC chemosensitivity by targeting SOX4
Weizheng Zhou et al.
THORACIC CANCER (2022)
Identification and Validation Prognostic Impact of MiRNA-30a-5p in Lung Adenocarcinoma
Xiulin Jiang et al.
FRONTIERS IN ONCOLOGY (2022)
The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor
Emad A. Ahmed et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The Polymorphism and Expression of EGFL7 and miR-126 Are Associated With NSCLC Susceptibility
Weipeng Liu et al.
FRONTIERS IN ONCOLOGY (2022)
Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer
A. S. Pal et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC
Simon Garinet et al.
BRITISH JOURNAL OF CANCER (2021)
Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer
Xiaohan Dong et al.
THORACIC CANCER (2021)
Evaluation of microRNAs as potential biomarkers in circulating HPV-DNA-positive non-small cell lung cancer patients
Yao Wu et al.
CANCER BIOLOGY & THERAPY (2021)
Upregulation of Serum m R-629 Predicts Poor Prognosis for NonSmall-Cell Lung Cancer
Fayong Liu et al.
DISEASE MARKERS (2021)
Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer
Junbo Xia et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients
Anna Grenda et al.
FRONTIERS IN ONCOLOGY (2021)
Diagnostic value of PPARδ and miRNA-17 expression levels in patients with non-small cell lung cancer
Monika Migdalska-Sek et al.
SCIENTIFIC REPORTS (2021)
Clinico-Pathological Importance of miR-146a in Lung Cancer
Javaid Ahmad Wani et al.
DIAGNOSTICS (2021)
Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients
Keatdamrong Janpipatkul et al.
CANCER BIOMARKERS (2021)
MiR-129-5p Promotes Radio-sensitivity of NSCLC Cells by Targeting SOX4 and RUNX1
Tongqing Xue et al.
CURRENT CANCER DRUG TARGETS (2021)
Circulating miR-21-5p and miR-126-3p: diagnostic, prognostic value, and multivariate analysis in non-small-cell lung cancer
Shimaa El-Shafey Soliman et al.
MOLECULAR BIOLOGY REPORTS (2021)
mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9
Bo Liu et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Micro-RNA: The darkhorse of cancer
Mridul Budakoti et al.
CELLULAR SIGNALLING (2021)
The potential diagnostic value of extracellular vesicle miRNA for human non-small cell lung cancer: a systematic review and meta-analysis
Hairong Huang et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2021)
Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data
Qing Ye et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis
Zhiyu Song et al.
LIFE SCIENCES (2021)
Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling
Daniela Di Paolo et al.
MOLECULAR ONCOLOGY (2021)
Knockdown of miR-15b partially reverses the cisplatin resistance of NSCLC through the GSK-3β/MCL-1 pathway
Tianjian Lu et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2021)
A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer
Alexia Monastirioti et al.
CELLS (2021)
Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs
Alessandro Leonetti et al.
CELLS (2021)
MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy
Yuanyuan Liang et al.
BIOMEDICINES (2021)
Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death
Feng Shi et al.
BIOENGINEERED (2021)
MicroRNA-25-3p promotes cisplatin resistance in Non-small-cell lung carcinoma (NSCLC) through adjusting PTEN/PI3K/AKT route
Butong Sun et al.
BIOENGINEERED (2021)
MiR-30a sensitized lung cancer against neoadjuvant chemotherapy by depressing autophagy
Xiao Lin et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2021)
miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2
Ke-Gang Jia et al.
JOURNAL OF BIOCHEMISTRY (2020)
Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses
Feifeng Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Micro(RNA) Management and Mismanagement of the Islet
Lena Eliasson et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip
Li Gao et al.
BMC MEDICAL GENOMICS (2020)
miR-29b inhibits non-small cell lung cancer progression by targeting STRN4
Yuping Xie et al.
HUMAN CELL (2020)
Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer
Lin Sun et al.
BIOSCIENCE REPORTS (2020)
Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer
Xiang Jin et al.
BMC CANCER (2020)
MiR-206 may suppress non-small lung cancer metastasis by targeting CORO1C
Ming Liao et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2020)
Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer
Ning Wang et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
MicroRNA-92b acts as an oncogene by targetingPTEN/AKTinNSCLC
Jia-Hui Guo et al.
CELL BIOCHEMISTRY AND FUNCTION (2020)
A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer
Chengwei Zhou et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)
Bioinformatics analysis of the circRNA-miRNA-mRNA network for non-small cell lung cancer
Xueying Cai et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)
Development of a serum miRNA panel for detection of early stage non-small cell lung cancer
Lisha Ying et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6
Mingjun Li et al.
CANCER CELL INTERNATIONAL (2020)
miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells
Nicholas J. Monteleone et al.
Oncotarget (2020)
Bioinformatics analysis to determine the prognostic value and prospective pathway signaling of miR-126 in non-small cell lung cancer
Zichen Jiao et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
The role of monoamine oxidase A in HPV-16 E7-induced epithelial-mesenchymal transition and HIF-1α protein accumulation in non-small cell lung cancer cells
Bingyu Huang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway
Lin Zhu et al.
CANCER BIOMARKERS (2020)
Beyond Conventional: The New Horizon of Anti-Angiogenic microRNAs in Non-Small Cell Lung Cancer Therapy
Alexandru Tirpe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
被撤回的出版物: Diagnostic Valuation of Serum miR-184 and miR-191 in Patients With Non-Small-Cell Lung Cancer (Retracted article. See vol. 30, 2023)
Hao Ding et al.
CANCER CONTROL (2020)
Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer
Pichitpon Chaniad et al.
PLOS ONE (2020)
Update 2020: Management of Non-Small Cell Lung Cancer
Mariam Alexander et al.
LUNG (2020)
Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer
Huifang Nie et al.
NANOSCALE (2020)
MiR-494 acts as a tumor promoter by targeting CASP2 in non-small cell lung cancer
Qiao Zhang et al.
SCIENTIFIC REPORTS (2019)
The Interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) Progression
Sook Shien Lee et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Clinical significance of serum miR-25 in non-small-cell lung cancer
J. Li et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2019)
Tumor suppressor function of miR-129-5p in lung cancer
Ge Li et al.
ONCOLOGY LETTERS (2019)
miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway
Tangwei Wu et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
MicroRNA-191 targets CCAAT/enhanced binding protein β and functions as an oncogenic molecule in human non-small cell lung carcinoma cells
Fuliang Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
Narjust Duma et al.
MAYO CLINIC PROCEEDINGS (2019)
Diagnosis of Non-small Cell Lung Cancer for Early Stage Asymptomatic Patients
Cherylle Goebel et al.
CANCER GENOMICS & PROTEOMICS (2019)
Update on Immunohistochemistry for the Diagnosis of Lung Cancer
Kentaro Inamura
CANCERS (2018)
Roles of miR-200 family members in lung cancer: more than tumor suppressors
Cong Liu et al.
FUTURE ONCOLOGY (2018)
The effect of microRNA-129 on the migration and invasion in NSCLC cells and its mechanism
Cao Bin et al.
EXPERIMENTAL LUNG RESEARCH (2018)
miR-33a inhibits cell proliferation and invasion by targeting CAND1 in lung cancer
M. Kang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2018)
miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells
Weihua Zhang et al.
JOURNAL OF DRUG TARGETING (2017)
miRNA-375 regulates the cell survival and apoptosis of human non-small cell carcinoma by targeting HER2
Longqiang Cheng et al.
MOLECULAR MEDICINE REPORTS (2017)
被撤回的出版物: miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3 (Retracted article. See vol. 26, 2022)
Zhonghai Zhao et al.
MOLECULAR MEDICINE REPORTS (2017)
Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection
Maria Sromek et al.
CELLULAR ONCOLOGY (2017)
Progress and prospects of early detection in lung cancer
Sean Blandin Knight et al.
OPEN BIOLOGY (2017)
Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies
Michael Yousef et al.
CANCERS (2017)
The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases
Akiteru Goto et al.
PLOS ONE (2017)
MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2
Jing Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma
Laura Boldrini et al.
CANCER CELL INTERNATIONAL (2017)
Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing
Xiance Jin et al.
CLINICAL CANCER RESEARCH (2017)
miR-98 inhibits expression of TWIST to prevent progression of non-small cell lung cancers
Haiyu Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase
Ting Lei et al.
MOLECULAR MEDICINE REPORTS (2016)
miR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression
Zhiwei He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Inhibition of miR-191 contributes to radiation-resistance of two lung cancer cell lines by altering autophagy activity
Zhenkuan Liu et al.
CANCER CELL INTERNATIONAL (2015)
The Role of miR-21 in Cancer
Susan R. Pfeffer et al.
DRUG DEVELOPMENT RESEARCH (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Longitudinal analysis of 2293 NSCLC patients: A comprehensive study from the TYROL registry
Florian Kocher et al.
LUNG CANCER (2015)
被撤回的出版物: miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo (Retracted article. See vol. 49, 2023)
Xingyu Lin et al.
ONCOLOGY REPORTS (2015)
Oncogenic miR-9 is a target of erlotinib in NSCLCs
Xi Chen et al.
SCIENTIFIC REPORTS (2015)
miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy
Fang Wang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
miR-4782-3p Inhibited Non-Small Cell Lung Cancer growth via USP14
Ning Wu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Downregulation of miR-638 promotes invasion and proliferation by regulating SOX2 and induces EMT in NSCLC
Yang Xia et al.
FEBS LETTERS (2014)
Decreased circulating miR-375: A potential biomarker for patients with non-small-cell lung cancer
Hong Yu et al.
GENE (2014)
Large cell carcinoma of lung: On the verge of extinction?
Annikka Weissferdt
SEMINARS IN DIAGNOSTIC PATHOLOGY (2014)
MiR-200c Increases the Radiosensitivity of Non-Small-Cell Lung Cancer Cell Line A549 by Targeting VEGF-VEGFR2 Pathway
Liangliang Shi et al.
PLOS ONE (2013)
Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers
Jin Sung Jang et al.
CLINICAL CANCER RESEARCH (2012)
Decreased Expression of MicroRNA-375 in Nonsmall Cell Lung Cancer and its Clinical Significance
Y. Li et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Lung Cancer Epidemiology, Risk Factors, and Prevention
Patricia de Groot et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2012)
Sputum MicroRNA Profiling: A Novel Approach for the Early Detection of Non-Small Cell Lung Cancer
Wilson H. Roa et al.
CLINICAL AND INVESTIGATIVE MEDICINE (2012)
Prognostic Implications of miR-16 Expression Levels in Resected Non-Small-Cell Lung Cancer
Alfons Navarro et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer
Maria Teresa Landi et al.
CLINICAL CANCER RESEARCH (2010)
Circulating miRNA and cancer diagnosis
Tie Yi et al.
SCIENCE IN CHINA SERIES C-LIFE SCIENCES (2009)
Serum MicroRNAs Are Promising Novel Biomarkers
Shlomit Gilad et al.
PLOS ONE (2008)
Lung cancer in never smokers - a different disease
Sophie Sun et al.
NATURE REVIEWS CANCER (2007)
RNAi, microRNAs, and human disease
Scott M. Hammond
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)